Advate (Hemophilia A and B)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 10
3 Disease Overview 11
3.1 Etiology and Pathophysiology 11
3.1.1 Etiology 11
3.1.2 Pathophysiology 12
3.1.3 Prognosis and Quality of Life 14
3.2 Symptoms 15
3.2.1 Hemophilia A and B 15
3.2.2 Inhibitors 16
4 Disease Management 17
4.1 Treatment Overview 17
4.1.1 Hemophilia A and B Diagnosis 18
4.1.2 Hemophilia A and B Treatment 18
4.1.3 Inhibitors Diagnosis 20
4.1.4 Inhibitors Treatment 20
5 Competitive Assessment 22
5.1 Overview 22
5.2 Strategic Competitive Assessment 23
6 Advate (octocog alfa) 27
6.1 Overview 27
6.2 Efficacy 28
6.3 Safety 30
6.4 SWOT Analysis 30
6.5 Forecast 31
7 Appendix 32
7.1 Bibliography 32
7.2 Abbreviations 34
7.3 Methodology 37
7.4 Forecasting Methodology 37
7.4.1 Diagnosed Hemophilia Patients 37
7.4.2 Percent Drug-Treated Patients 38
7.4.3 General Pricing Assumptions 38
7.4.4 Individual Drug Assumptions 39
7.5 About the Authors 42
7.5.1 Authors 42
7.5.2 Global Head of Healthcare 43
7.6 About GlobalData 44
7.7 Disclaimer 44